Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Lainas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|February 24, 2015
Authors' replyT G Lainas, E M Kolibianakis
Human Reproduction (Oxford, England)|August 26, 2023
Follicular flushing increases the number of oocytes retrieved: a randomized controlled trialG T Lainas, T G Lainas, A A Makris, et al.
Reproductive Biomedicine Online|October 3, 2007
Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonistT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Reproductive Biomedicine Online|December 25, 2009
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phaseT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Human Reproduction (Oxford, England)|April 30, 2013
Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSSG T Lainas, E M Kolibianakis, I A Sfontouris, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 14, 2014
Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndromeG T Lainas, E M Kolibianakis, I A Sfontouris, et al.
Reproductive Biomedicine Online|January 17, 2009
Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocolT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 7, 2017
Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndromeG T Lainas, T G Lainas, C A Venetis, et al.
Human Reproduction Open|June 13, 2020
A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCGG T Lainas, T G Lainas, I A Sfontouris, et al.
Human Reproduction (Oxford, England)|August 7, 2019
Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?G T Lainas, T G Lainas, I A Sfontouris, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BJOG : an International Journal of Obstetrics and Gynaecology|February 24, 2015
Authors' replyT G Lainas, E M Kolibianakis
Human Reproduction (Oxford, England)|August 26, 2023
Follicular flushing increases the number of oocytes retrieved: a randomized controlled trialG T Lainas, T G Lainas, A A Makris, et al.
Reproductive Biomedicine Online|October 3, 2007
Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonistT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Reproductive Biomedicine Online|December 25, 2009
Live births after management of severe OHSS by GnRH antagonist administration in the luteal phaseT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Human Reproduction (Oxford, England)|April 30, 2013
Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSSG T Lainas, E M Kolibianakis, I A Sfontouris, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 14, 2014
Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndromeG T Lainas, E M Kolibianakis, I A Sfontouris, et al.
Reproductive Biomedicine Online|January 17, 2009
Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocolT G Lainas, I A Sfontouris, I Z Zorzovilis, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 7, 2017
Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndromeG T Lainas, T G Lainas, C A Venetis, et al.
Human Reproduction Open|June 13, 2020
A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggering final oocyte maturation with hCGG T Lainas, T G Lainas, I A Sfontouris, et al.
Human Reproduction (Oxford, England)|August 7, 2019
Is oocyte maturation rate associated with triptorelin dose used for triggering final oocyte maturation in patients at high risk for severe ovarian hyperstimulation syndrome?G T Lainas, T G Lainas, I A Sfontouris, et al.
Pageof 2